Jerzy Windyga

21PUBLICATIONS
82CO-AUTHORS
Adolescent healthRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 11, 2026
Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

|Jul 24, 2026
Guidelines for Minimizing Bleeding Risk During Bronchoscopic Procedures.

|Jul 17, 2026
Denecimig (Mim8) prophylaxis once-every-2-weeks for hemophilia A with or without inhibitors - 26-week results from FRONTIER.

|Jun 24, 2026
Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study.

|Jul 17, 2025
Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors.

Manuel Carcao, Cédric Hermans, Adam Giermasz

|Jul 20, 2024
Disease and treatment burden of patients with haemophilia entering the explorer6 non-interventional study.

Jerzy Windyga, Shashikant Apte, Melissa Frei-Jones

Pageof 4

Frequent Collaborators

5 joint publications

Johnny N Mahlangu

3 joint publications

Guy Young

2 joint publications

Masanori Matsumoto

2 joint publications

Craig Kessler